Replies to post #235679 on Biotech Values

[rwwine]

Based on this, I foresee the same announcement apropos RVNC and the application of DaxibotulinumtoxinA.

[DewDiligence]

FDA approves BMY’s Breyanzi (liso-cel) for B-cell lymphomas:

https://www.prnewswire.com/news-releases/fda-approves-new-treatment-for-adults-with-relapsed-or-refractory-large-b-cell-lymphoma-301223275.html